US2021100452A1PendingUtilityA1

Transcutaneous analyte sensor

Assignee: DEXCOM INCPriority: Sep 13, 2007Filed: Nov 24, 2020Published: Apr 8, 2021

Est. expirySep 13, 2027(~1.1 yrs left)· nominal 20-yr term from priority

Inventors:Mark C. Brister Jack Pryor John Nolting Jacob S. Leach Luis Pestana Nelson Quintana Vance Swanson Paul V. Goode James Patrick Thrower

A61B 5/6848A61B 5/14546Y02A90/10A61B 5/1411A61B 5/0002A61B 5/6849A61B 5/14865A61B 2560/0214A61B 5/14532A61B 2562/08A61B 5/6832G16Z 99/00A61B 5/150534A61B 2560/0223A61B 5/6833A61B 5/150022A61B 5/14507A61B 5/1473A61B 5/0022A61B 5/742A61B 5/1486

PatentIndex Score

Cited by

References

Claims

Abstract

The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.

Claims

exact text as granted — not AI-modified

1 - 20 . (canceled) 
     
     
         21 . A transcutaneous analyte sensor system comprising:
 a transcutaneous analyte sensor; and   sensor electronics operably connectable to the transcutaneous analyte sensor.

Join the waitlist — get patent alerts

Track US2021100452A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.